Home / Health / Weight-Loss Drug Helped Detect Life-Saving Cancer
Weight-Loss Drug Helped Detect Life-Saving Cancer
11 Feb
Summary
- Mounjaro use led to discovery of fast-acting stage two breast cancer.
- Doctors stated weight loss was crucial for detecting the lump early.
- The patient is undergoing chemotherapy and hormone blocker treatment.
A woman has credited the weight-loss medication Mounjaro with saving her life after it facilitated the early detection of stage two breast cancer. Rebecca Combellack, aged 37, was diagnosed in May 2025 following the discovery of a lump. She had begun using Mounjaro in April 2025, motivated by her weight gain during a skiing holiday.
Combellack lost over two stone in two months, a process that revealed a small lump. Doctors indicated that her reduced weight was instrumental in feeling the lump, noting the cancer's aggressive nature. Had she not lost weight, the outcome could have been significantly worse.
The diagnosis was estrogen receptor-positive breast cancer. Following surgery to remove the lump, she commenced chemotherapy in August 2025. Rebecca continues to manage her business and family life while undergoing treatment, supported by her husband, Richard.
The couple has actively engaged in charity work, raising tens of thousands of pounds for Breast Cancer Now and CoppaFeel. Richard organized a charity ice hockey match to support their cause. Rebecca is on a lifelong hormone blocker, which induces early menopause, impacting their ability to have more children. She emphasizes the importance of humor and positivity throughout her challenging experience.
